BULLISH (BLSH) Fundamental Analysis & Valuation

NYSE:BLSH • KYG169101204

34.96 USD
-0.06 (-0.17%)
At close: Mar 6, 2026
34.8695 USD
-0.09 (-0.26%)
After Hours: 3/6/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This BLSH fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BLSH. BLSH was compared to 238 industry peers in the Capital Markets industry. While BLSH seems to be doing ok healthwise, there are quite some concerns on its profitability. BLSH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. BLSH Profitability Analysis

1.1 Basic Checks

  • BLSH had negative earnings in the past year.
  • In multiple years BLSH reported negative net income over the last 5 years.
  • In the past 5 years BLSH reported 4 times negative operating cash flow.
BLSH Yearly Net Income VS EBIT VS OCF VS FCFBLSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 1B -1B -2B -3B -4B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -16.54%, BLSH is doing worse than 86.97% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -19.52%, BLSH is doing worse than 78.99% of the companies in the same industry.
Industry RankSector Rank
ROA -16.54%
ROE -19.52%
ROIC N/A
ROA(3y)18.41%
ROA(5y)-17.64%
ROE(3y)26.99%
ROE(5y)-33.49%
ROIC(3y)N/A
ROIC(5y)N/A
BLSH Yearly ROA, ROE, ROICBLSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 100 -100 -200

1.3 Margins

  • BLSH's Gross Margin of 0.03% is on the low side compared to the rest of the industry. BLSH is outperformed by 68.91% of its industry peers.
  • BLSH's Gross Margin has declined in the last couple of years.
  • BLSH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.03%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.92%
GM growth 5YN/A
BLSH Yearly Profit, Operating, Gross MarginsBLSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. BLSH Health Analysis

2.1 Basic Checks

  • BLSH has more shares outstanding than it did 1 year ago.
  • BLSH has more shares outstanding than it did 5 years ago.
  • BLSH has a better debt/assets ratio than last year.
BLSH Yearly Shares OutstandingBLSH Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M
BLSH Yearly Total Debt VS Total AssetsBLSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 58.06 indicates that BLSH is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 58.06, BLSH belongs to the top of the industry, outperforming 97.90% of the companies in the same industry.
  • BLSH has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of BLSH (0.14) is better than 77.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Altman-Z 58.06
ROIC/WACCN/A
WACCN/A
BLSH Yearly LT Debt VS Equity VS FCFBLSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 2B 4B 6B

2.3 Liquidity

  • BLSH has a Current Ratio of 38.78. This indicates that BLSH is financially healthy and has no problem in meeting its short term obligations.
  • BLSH has a Current ratio of 38.78. This is amongst the best in the industry. BLSH outperforms 99.58% of its industry peers.
  • BLSH has a Quick Ratio of 36.58. This indicates that BLSH is financially healthy and has no problem in meeting its short term obligations.
  • BLSH has a Quick ratio of 36.58. This is amongst the best in the industry. BLSH outperforms 99.58% of its industry peers.
Industry RankSector Rank
Current Ratio 38.78
Quick Ratio 36.58
BLSH Yearly Current Assets VS Current LiabilitesBLSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BLSH Growth Analysis

3.1 Past

  • BLSH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1229.62%.
  • BLSH shows a decrease in Revenue. In the last year, the revenue decreased by -2.15%.
  • The Revenue has been growing by 49.76% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1229.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y49.76%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, BLSH will show a very strong growth in Earnings Per Share. The EPS will grow by 71.09% on average per year.
  • BLSH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.87% yearly.
EPS Next Y169.8%
EPS Next 2Y99.69%
EPS Next 3Y71.09%
EPS Next 5YN/A
Revenue Next Year36.62%
Revenue Next 2Y25.94%
Revenue Next 3Y23.87%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BLSH Yearly Revenue VS EstimatesBLSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 50B 100B 150B 200B 250B
BLSH Yearly EPS VS EstimatesBLSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

2

4. BLSH Valuation Analysis

4.1 Price/Earnings Ratio

  • BLSH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 45.44, the valuation of BLSH can be described as expensive.
  • 71.85% of the companies in the same industry are cheaper than BLSH, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of BLSH to the average of the S&P500 Index (24.57), we can say BLSH is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 45.44
BLSH Price Earnings VS Forward Price EarningsBLSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLSH Per share dataBLSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K

4.3 Compensation for Growth

  • BLSH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as BLSH's earnings are expected to grow with 71.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y99.69%
EPS Next 3Y71.09%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLSH Dividend Analysis

5.1 Amount

  • BLSH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLSH Fundamentals: All Metrics, Ratios and Statistics

BULLISH

NYSE:BLSH (3/6/2026, 8:04:00 PM)

After market: 34.8695 -0.09 (-0.26%)

34.96

-0.06 (-0.17%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)02-05
Earnings (Next)N/A
Inst Owners18.15%
Inst Owner ChangeN/A
Ins Owners68.11%
Ins Owner ChangeN/A
Market Cap5.11B
Revenue(TTM)244.81B
Net Income(TTM)-764.68M
Analysts75.56
Price Target46.21 (32.18%)
Short Float %56.38%
Short Ratio4.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-47.32%
Min EPS beat(2)-93.83%
Max EPS beat(2)-0.81%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.66%
Min Revenue beat(2)-0.02%
Max Revenue beat(2)5.34%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.23%
PT rev (3m)-25.12%
EPS NQ rev (1m)1.77%
EPS NQ rev (3m)1.59%
EPS NY rev (1m)-1.12%
EPS NY rev (3m)-8.63%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)-0.85%
Revenue NY rev (3m)5.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 45.44
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 1.3
P/tB 1.34
EV/EBITDA N/A
EPS(TTM)-5.07
EYN/A
EPS(NY)0.77
Fwd EY2.2%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1674.73
BVpS26.8
TBVpS26.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -16.54%
ROE -19.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.03%
FCFM N/A
ROA(3y)18.41%
ROA(5y)-17.64%
ROE(3y)26.99%
ROE(5y)-33.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-36.92%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover52.95
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 38.78
Quick Ratio 36.58
Altman-Z 58.06
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1229.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y169.8%
EPS Next 2Y99.69%
EPS Next 3Y71.09%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.15%
Revenue growth 3Y49.76%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year36.62%
Revenue Next 2Y25.94%
Revenue Next 3Y23.87%
Revenue Next 5YN/A
EBIT growth 1Y62.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year194.55%
EBIT Next 3Y69.77%
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BULLISH / BLSH FAQ

What is the fundamental rating for BLSH stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLSH.


What is the valuation status of BULLISH (BLSH) stock?

ChartMill assigns a valuation rating of 2 / 10 to BULLISH (BLSH). This can be considered as Overvalued.


Can you provide the profitability details for BULLISH?

BULLISH (BLSH) has a profitability rating of 0 / 10.


Can you provide the financial health for BLSH stock?

The financial health rating of BULLISH (BLSH) is 6 / 10.